Shares of Udemy, Inc. (NASDAQ:UDMY – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve brokerages that are covering the company, Marketbeat.com reports. One ...

Equities research analysts at William Blair cut their Q4 2025 earnings per share estimates for Tetra Tech in a research note ...

William Blair analyst Matt Phipps maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today. The company’s shares ...

LPL Financial Holdings Inc. (NASDAQ: LPLA) (together with its subsidiaries, including LPL Financial LLC, “LPL Financial” or “LPL”) today announced the pricing of an underwritten public offering of ...

Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration’s top vaccine official was forced to resign, the most high-profile exit at the regulator as the ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Unlike other hemophilia therapies, Qfitlia is indicated for both hemophilia A and B, and can be given in patients regardless ...

Much of the attention this week for markets and economists will center on the rollout of President Donald Trump’s tariffs.

Walmart makes up a relatively small portion of Affirm’s business that the buy now, pay later company can make up elsewhere, ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...

Over a 15-year span, Sweetgreen expanded fivefold to 150 locations as it approached the doorstep of going public in late 2021 ...